Endo International PLC (ENDPQ)
0.0006
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Endo International Enterprise Value: -777.78M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 01, 2024 | -777.78M |
April 30, 2024 | -777.78M |
April 29, 2024 | -777.78M |
April 26, 2024 | -777.78M |
April 25, 2024 | -777.78M |
April 24, 2024 | -777.78M |
April 23, 2024 | -777.78M |
April 22, 2024 | -777.75M |
April 19, 2024 | -777.75M |
April 18, 2024 | -777.78M |
April 17, 2024 | -777.78M |
April 16, 2024 | -776.98M |
April 15, 2024 | -777.50M |
April 12, 2024 | -777.85M |
April 11, 2024 | -777.85M |
April 10, 2024 | -777.87M |
April 09, 2024 | -777.90M |
April 08, 2024 | -777.82M |
April 05, 2024 | -777.68M |
April 04, 2024 | -777.80M |
April 03, 2024 | -777.82M |
April 02, 2024 | -777.82M |
April 01, 2024 | -777.82M |
March 28, 2024 | -777.82M |
March 27, 2024 | -777.82M |
Date | Value |
---|---|
March 26, 2024 | -777.85M |
March 25, 2024 | -777.80M |
March 22, 2024 | -777.80M |
March 21, 2024 | -777.85M |
March 20, 2024 | -777.82M |
March 19, 2024 | -777.85M |
March 18, 2024 | -777.73M |
March 15, 2024 | -777.73M |
March 14, 2024 | -777.73M |
March 13, 2024 | -777.73M |
March 12, 2024 | -777.66M |
March 11, 2024 | -777.66M |
March 08, 2024 | -777.66M |
March 07, 2024 | -777.64M |
March 06, 2024 | -777.64M |
March 05, 2024 | -777.64M |
March 04, 2024 | -777.64M |
March 01, 2024 | -776.74M |
February 29, 2024 | -777.68M |
February 28, 2024 | -777.59M |
February 27, 2024 | -777.68M |
February 26, 2024 | -777.47M |
February 23, 2024 | -777.73M |
February 22, 2024 | -777.68M |
February 21, 2024 | -777.78M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-1.039B
Minimum
Dec 19 2022
9.533B
Maximum
Feb 22 2021
5.378B
Average
7.387B
Median
Jul 06 2020
Enterprise Value Benchmarks
Alkermes PLC | 3.615B |
Jazz Pharmaceuticals PLC | 10.83B |
Medtronic PLC | 125.48B |
Perrigo Co PLC | 7.766B |
Iterum Therapeutics PLC | 20.69M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -2.441B |
Revenue (Quarterly) | 497.73M |
Total Expenses (Quarterly) | 418.11M |
EPS Diluted (Quarterly) | -10.38 |
Gross Profit Margin (Quarterly) | 49.87% |
Profit Margin (Quarterly) | -490.5% |
Earnings Yield | -1.74M% |
Operating Earnings Yield | 270.6K% |
Normalized Earnings Yield | -189006.7 |